Global Small Molecule Targeted Cancer Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024


Jul, 2019 | Report ID: 83318 | 122 | Medical



Scope of the Report:

The global Small Molecule Targeted Cancer Therapy market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Small Molecule Targeted Cancer Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Small Molecule Targeted Cancer Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Small Molecule Targeted Cancer Therapy market by product type and applications/end industries.

Market Segment by Companies, this report covers

OncoGenex Pharmaceuticals, Inc.
Cytokinetics Inc.
Hospira Inc.
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
Bayer HealthCare AG
Abbott Laboratories

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Monoclonal Antibodies
Small Molecules
Small Molecule Drug Conjugates

Market Segment by Applications, can be divided into

Lymphoma
Melanoma
Multiple Myeloma
Breast Cancer
Prostate Cancer
Other Cancers

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents



1 Small Molecule Targeted Cancer Therapy Market Overview

1.1 Product Overview and Scope of Small Molecule Targeted Cancer Therapy

1.2 Classification of Small Molecule Targeted Cancer Therapy by Types

1.2.1 Global Small Molecule Targeted Cancer Therapy Revenue Comparison by Types (2019-2024)

1.2.2 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Types in 2018

1.2.3 Monoclonal Antibodies

1.2.4 Small Molecules

1.2.5 Small Molecule Drug Conjugates

1.3 Global Small Molecule Targeted Cancer Therapy Market by Application

1.3.1 Global Small Molecule Targeted Cancer Therapy Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Lymphoma

1.3.3 Melanoma

1.3.4 Multiple Myeloma

1.3.5 Breast Cancer

1.3.6 Prostate Cancer

1.3.7 Other Cancers

1.4 Global Small Molecule Targeted Cancer Therapy Market by Regions

1.4.1 Global Small Molecule Targeted Cancer Therapy Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Small Molecule Targeted Cancer Therapy Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Small Molecule Targeted Cancer Therapy Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Small Molecule Targeted Cancer Therapy Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Small Molecule Targeted Cancer Therapy Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Small Molecule Targeted Cancer Therapy Status and Prospect (2014-2024)

1.5 Global Market Size of Small Molecule Targeted Cancer Therapy (2014-2024)

2 Manufacturers Profiles

2.1 OncoGenex Pharmaceuticals, Inc.

2.1.1 Business Overview

2.1.2 Small Molecule Targeted Cancer Therapy Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)

2.2 Cytokinetics Inc.

2.2.1 Business Overview

2.2.2 Small Molecule Targeted Cancer Therapy Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)

2.3 Hospira Inc.

2.3.1 Business Overview

2.3.2 Small Molecule Targeted Cancer Therapy Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Hospira Inc. Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)

2.4 GlaxoSmithKline plc

2.4.1 Business Overview

2.4.2 Small Molecule Targeted Cancer Therapy Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)

2.5 Boehringer Ingelheim GmbH

2.5.1 Business Overview

2.5.2 Small Molecule Targeted Cancer Therapy Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)

2.6 Bayer HealthCare AG

2.6.1 Business Overview

2.6.2 Small Molecule Targeted Cancer Therapy Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)

2.7 Abbott Laboratories

2.7.1 Business Overview

2.7.2 Small Molecule Targeted Cancer Therapy Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)

3 Global Small Molecule Targeted Cancer Therapy Market Competition, by Players

3.1 Global Small Molecule Targeted Cancer Therapy Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Small Molecule Targeted Cancer Therapy Players Market Share

3.2.2 Top 10 Small Molecule Targeted Cancer Therapy Players Market Share

3.3 Market Competition Trend

4 Global Small Molecule Targeted Cancer Therapy Market Size by Regions

4.1 Global Small Molecule Targeted Cancer Therapy Revenue and Market Share by Regions

4.2 North America Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

4.3 Europe Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

4.5 South America Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

5 North America Small Molecule Targeted Cancer Therapy Revenue by Countries

5.1 North America Small Molecule Targeted Cancer Therapy Revenue by Countries (2014-2019)

5.2 USA Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

5.3 Canada Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

5.4 Mexico Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

6 Europe Small Molecule Targeted Cancer Therapy Revenue by Countries

6.1 Europe Small Molecule Targeted Cancer Therapy Revenue by Countries (2014-2019)

6.2 Germany Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

6.3 UK Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

6.4 France Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

6.5 Russia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

6.6 Italy Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue by Countries

7.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue by Countries (2014-2019)

7.2 China Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

7.3 Japan Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

7.4 Korea Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

7.5 India Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

8 South America Small Molecule Targeted Cancer Therapy Revenue by Countries

8.1 South America Small Molecule Targeted Cancer Therapy Revenue by Countries (2014-2019)

8.2 Brazil Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

8.3 Argentina Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

8.4 Colombia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Small Molecule Targeted Cancer Therapy by Countries

9.1 Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue by Countries (2014-2019)

9.2 Saudi Arabia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

9.3 UAE Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

9.4 Egypt Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

9.5 Nigeria Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

9.6 South Africa Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

10 Global Small Molecule Targeted Cancer Therapy Market Segment by Type

10.1 Global Small Molecule Targeted Cancer Therapy Revenue and Market Share by Type (2014-2019)

10.2 Global Small Molecule Targeted Cancer Therapy Market Forecast by Type (2019-2024)

10.3 Monoclonal Antibodies Revenue Growth Rate (2014-2024)

10.4 Small Molecules Revenue Growth Rate (2014-2024)

10.5 Small Molecule Drug Conjugates Revenue Growth Rate (2014-2024)

11 Global Small Molecule Targeted Cancer Therapy Market Segment by Application

11.1 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Application (2014-2019)

11.2 Small Molecule Targeted Cancer Therapy Market Forecast by Application (2019-2024)

11.3 Lymphoma Revenue Growth (2014-2019)

11.4 Melanoma Revenue Growth (2014-2019)

11.5 Multiple Myeloma Revenue Growth (2014-2019)

11.6 Breast Cancer Revenue Growth (2014-2019)

11.7 Prostate Cancer Revenue Growth (2014-2019)

11.8 Other Cancers Revenue Growth (2014-2019)

12 Global Small Molecule Targeted Cancer Therapy Market Size Forecast (2019-2024)

12.1 Global Small Molecule Targeted Cancer Therapy Market Size Forecast (2019-2024)

12.2 Global Small Molecule Targeted Cancer Therapy Market Forecast by Regions (2019-2024)

12.3 North America Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)

12.4 Europe Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)

12.6 South America Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Small Molecule Targeted Cancer Therapy Picture

Table Product Specifications of Small Molecule Targeted Cancer Therapy

Table Global Small Molecule Targeted Cancer Therapy and Revenue (Million USD) Market Split by Product Type

Figure Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Types in 2018

Figure Monoclonal Antibodies Picture

Figure Small Molecules Picture

Figure Small Molecule Drug Conjugates Picture

Table Global Small Molecule Targeted Cancer Therapy Revenue (Million USD) by Application (2014-2024)

Figure Small Molecule Targeted Cancer Therapy Revenue Market Share by Applications in 2018

Figure Lymphoma Picture

Figure Melanoma Picture

Figure Multiple Myeloma Picture

Figure Breast Cancer Picture

Figure Prostate Cancer Picture

Figure Other Cancers Picture

Table Global Market Small Molecule Targeted Cancer Therapy Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Small Molecule Targeted Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Small Molecule Targeted Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Small Molecule Targeted Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Small Molecule Targeted Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)

Table OncoGenex Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors

Table OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Type and Applications

Table OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)

Table Cytokinetics Inc. Basic Information, Manufacturing Base and Competitors

Table Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Type and Applications

Table Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)

Table Hospira Inc. Basic Information, Manufacturing Base and Competitors

Table Hospira Inc. Small Molecule Targeted Cancer Therapy Type and Applications

Table Hospira Inc. Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)

Table GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Type and Applications

Table GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)

Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors

Table Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Type and Applications

Table Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)

Table Bayer HealthCare AG Basic Information, Manufacturing Base and Competitors

Table Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Type and Applications

Table Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)

Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors

Table Abbott Laboratories Small Molecule Targeted Cancer Therapy Type and Applications

Table Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)

Table Global Small Molecule Targeted Cancer Therapy Revenue (Million USD) by Players (2014-2019)

Table Global Small Molecule Targeted Cancer Therapy Revenue Share by Players (2014-2019)

Figure Global Small Molecule Targeted Cancer Therapy Revenue Share by Players in 2017

Figure Global Small Molecule Targeted Cancer Therapy Revenue Share by Players in 2018

Figure Global Top 5 Players Small Molecule Targeted Cancer Therapy Revenue Market Share in 2018

Figure Global Top 10 Players Small Molecule Targeted Cancer Therapy Revenue Market Share in 2018

Figure Global Small Molecule Targeted Cancer Therapy Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Small Molecule Targeted Cancer Therapy Revenue (Million USD) by Regions (2014-2019)

Table Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Regions (2014-2019)

Figure Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Regions (2014-2019)

Figure Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Regions in 2018

Figure North America Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure Europe Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure South America Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Table North America Small Molecule Targeted Cancer Therapy Revenue by Countries (2014-2019)

Table North America Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries (2014-2019)

Figure North America Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries (2014-2019)

Figure North America Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries in 2018

Figure USA Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure Canada Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure Mexico Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Table Europe Small Molecule Targeted Cancer Therapy Revenue (Million USD) by Countries (2014-2019)

Figure Europe Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries (2014-2019)

Figure Europe Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries in 2018

Figure Germany Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure UK Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure France Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure Russia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure Italy Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries in 2018

Figure China Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure Japan Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure Korea Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure India Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Table South America Small Molecule Targeted Cancer Therapy Revenue by Countries (2014-2019)

Table South America Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries (2014-2019)

Figure South America Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries (2014-2019)

Figure South America Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries in 2018

Figure Brazil Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure Argentina Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure Colombia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries in 2018

Figure Saudi Arabia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure UAE Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure Egypt Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure Nigeria Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Figure South Africa Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)

Table Global Small Molecule Targeted Cancer Therapy Revenue (Million USD) by Type (2014-2019)

Table Global Small Molecule Targeted Cancer Therapy Revenue Share by Type (2014-2019)

Figure Global Small Molecule Targeted Cancer Therapy Revenue Share by Type (2014-2019)

Figure Global Small Molecule Targeted Cancer Therapy Revenue Share by Type in 2019

Table Global Small Molecule Targeted Cancer Therapy Revenue Forecast by Type (2019-2024)

Figure Global Small Molecule Targeted Cancer Therapy Market Share Forecast by Type (2019-2024)

Figure Global Monoclonal Antibodies Revenue Growth Rate (2014-2019)

Figure Global Small Molecules Revenue Growth Rate (2014-2019)

Figure Global Small Molecule Drug Conjugates Revenue Growth Rate (2014-2019)

Table Global Small Molecule Targeted Cancer Therapy Revenue by Application (2014-2019)

Table Global Small Molecule Targeted Cancer Therapy Revenue Share by Application (2014-2019)

Figure Global Small Molecule Targeted Cancer Therapy Revenue Share by Application (2014-2019)

Figure Global Small Molecule Targeted Cancer Therapy Revenue Share by Application in 2019

Table Global Small Molecule Targeted Cancer Therapy Revenue Forecast by Application (2019-2024)

Figure Global Small Molecule Targeted Cancer Therapy Market Share Forecast by Application (2019-2024)

Figure Global Lymphoma Revenue Growth Rate (2014-2019)

Figure Global Melanoma Revenue Growth Rate (2014-2019)

Figure Global Multiple Myeloma Revenue Growth Rate (2014-2019)

Figure Global Breast Cancer Revenue Growth Rate (2014-2019)

Figure Global Prostate Cancer Revenue Growth Rate (2014-2019)

Figure Global Other Cancers Revenue Growth Rate (2014-2019)

Figure Global Small Molecule Targeted Cancer Therapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Small Molecule Targeted Cancer Therapy Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Small Molecule Targeted Cancer Therapy Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)

Figure Europe Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)

Figure South America Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)

Sample Request is not available